Utah Chapter of the American College of Cardiology

Eagleâ€™s Eye View: Your Weekly CV Update from ACC.org (Week of August 15)
In this weekâ€™s View, Dr. Eagle discusses the impact of medication non-adherence in a clinical trial of dual antiplatelet therapy, then looks at sex difference in outcomes following transcatheter aortic valve replacement in bicuspid aortic stenosis.
NLA 2022 Definition of Statin Intolerance
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death globally and remains a major cause of morbidity, mortality, and disability.
Trans-Atlantic Network to study Stepwise Non-invasive Imaging as a tool for CVD Prognosis and prevention
The goal of the TANSNIP-PESA trial was to evaluate comprehensive lifestyle intervention compared with control among asymptomatic individuals.
PDAY Risk Score Predicts Cardiovascular Events in Young Adults
Can the PDAY (Pathobiologic Determinants of Atherosclerosis in Youth) risk score predict risk for coronary artery disease?
Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction
The goal of the DAPA-HF trial was to evaluate dapagliflozin (a sodium-glucose cotransporter 2 [SGLT2] inhibitor) compared with placebo among patients with heart failure with reduced ejection fraction (HFrEF).